H. Hieronymus

发表

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Paul A Clemons, Aravind Subramanian, Steven A Carr, 2006, Science.

Integrative genomic profiling of human prostate cancer.

C. Sander, H. Hieronymus, W. Gerald, 2010, Cancer cell.

Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis

Haley Hieronymus, H. Hieronymus, A. Gopalan, 2017, Nature Communications.

Genome-Wide Localization of the Nuclear Transport Machinery Couples Transcriptional Status and Nuclear Organization

Pamela A. Silver, Haley Hieronymus, H. Hieronymus, 2004, Cell.

Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

T. Golub, W. Hahn, J. Lamb, 2006, Cancer cell.

Genome-wide mRNA surveillance is coupled to mRNA export.

H. Hieronymus, P. Silver, Michael C Yu, 2004, Genes & development.

Genome-wide analysis of RNA–protein interactions illustrates specificity of the mRNA export machinery

H. Hieronymus, P. Silver, 2003, Nature Genetics.

A public genome-scale lentiviral expression library of human ORFs

Thomas M Green, W. Hahn, H. Hieronymus, 2011, Nature Methods.

MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors

Chris Sander, Barry S. Taylor, Haley Hieronymus, 2011, PloS one.

Is / 3 ,-Antagonism Essential for the Antihypertensive Action of / 3-Blockers ?

H. Hieronymus, Vincent, 2005 .

Androgen receptor signaling regulates DNA repair in prostate cancers.

H. Hieronymus, P. Scardino, M. Zelefsky, 2013, Cancer discovery.

COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation

Marc Vidal, Reinhard Dummer, William C. Hahn, 2010, Nature.

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR

H. Hieronymus, G. Hannon, J. Parker, 2011, Nature.

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

C. Sander, H. Hieronymus, W. Gerald, 2009, Nature Genetics.

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

H. Hieronymus, M. Rubin, A. Tewari, 2014, Neoplasia.

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

Jack Cuzick, Nikolaus Schultz, Henrik Moller, 2018, eLife.

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.

Sarat Chandarlapaty, Neal Rosen, Peter T. Scardino, 2011, Cancer cell.

MP41-06 SPOP MUTATIONS IN PROSTATE CANCER ACROSS DEMOGRAPHICALLY DIVERSE PATIENT COHORTS.

Kevin T. Turner, H. Hieronymus, M. Rubin, 2014 .

Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts 1 , 2

H. Hieronymus, M. Rubin, A. Tewari, 2014 .

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome

S. Horvath, H. Hieronymus, D. Elashoff, 2016, Cell reports.

Low CD 38 Identifies Proge nitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome Graphical Abstract Highlights

S. Horvath, H. Hieronymus, D. Elashoff, 2016 .

Traversing the genomic landscape of prostate cancer from diagnosis to death

H. Hieronymus, C. Sawyers, 2012, Nature Genetics.

Copy number alteration burden predicts prostate cancer relapse

Chris Sander, Yonghong Xiao, Nikolaus Schultz, 2014, Proceedings of the National Academy of Sciences.

Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes

H. Hieronymus, A. Gopalan, B. Carver, 2019, Molecular Cancer Therapeutics.

Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

T. Golub, H. Hieronymus, S. Carr, 2009, Nature Biotechnology.

Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors

H. Hieronymus, S. Achilefu, M. Schwaiger, 2018, The Journal of experimental medicine.

Identifying Actionable Targets through Integrative Analyses of GEM Model and Human Prostate Cancer Genomic Profiling

C. Sander, H. Hieronymus, B. Taylor, 2014, Molecular Cancer Therapeutics.

A systems view of mRNP biology.

H. Hieronymus, P. Silver, 2004, Genes & development.

Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening

Kenneth Chang, Gregory J. Hannon, Joel S. Parker, 2012, PloS one.

Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

H. Hieronymus, N. Rosen, A. Gopalan, 2020, Cancer Research.

Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis

H. Hieronymus, A. Gopalan, B. Carver, 2017, Nature Communications.

COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation

T. Golub, W. Hahn, H. Hieronymus, 2010, Nature.

A public genome-scale lentiviral expression library of human ORFs

Thomas M Green, W. Hahn, H. Hieronymus, 2011, Nature Methods.